CDH3 and breast cancer: Taken together, potential sources of discordant subtyping among participants included E‐cadherin‐positive BC of NST with trabecular growth pattern, CDH1 missense mutations associated with preserved E‐cadherin protein expression, and E‐ to P‐cadherin switching in ILC with tubular elements.